Lannett Makes Deal For Respirent’s Flovent Diskus Rival

Also Extends Distribution Term for Advair Rival To 12 Years

 
• By Akriti Seth
  
Lungs
Lannett continues to expand its portfolio for inhalation medications • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business